BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Jiehua Lin, Feng Yan, Xiaoya Hu, Huangxian Ju. Chemiluminescent immunosensor for CA19-9 based on antigen immobilization on a cross-linked chitosan membraneJournal of Immunological Methods 2004; 291(1-2): 165 doi: 10.1016/j.jim.2004.06.001
2
X.G. Ni, X.F. Bai, Y.L. Mao, Y.F. Shao, J.X. Wu, Y. Shan, C.F. Wang, J. Wang, Y.T. Tian, Q. Liu, D.K. Xu, P. Zhao. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancerEuropean Journal of Surgical Oncology (EJSO) 2005; 31(2): 164 doi: 10.1016/j.ejso.2004.09.007
3
Dong WU, Jia Ming QIAN, Rui Xue DENG, Wei Jun JIANG, Yuan Jia CHEN, Xiao Hong LIU, Xing Hua LU. Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancerChinese Journal of Digestive Diseases 2006; 7(2): 117 doi: 10.1111/j.1443-9573.2006.00249.x
4
Mohamed M. Abdel-Aziz, Mahmoud Lotfy, Ibrahim M. El-Kady, Mostafa Abozaid. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptorCancer Detection and Prevention 2009; 32(4): 329 doi: 10.1016/j.cdp.2005.10.006
5
Xing-Lei Qin, Zuo-Ren Wang, Jing-Sen Shi, Min Lu, Lin Wang, Quan-Ru He. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEAWorld Journal of Gastroenterology 2004; 10(3): 427-432 doi: 10.3748/wjg.v10.i3.427
6
Tsann-Long Hwang, Ying Liang, Kuan-Yi Chien, Jau-Song Yu. Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinomaPROTEOMICS 2006; 6(7): 2259 doi: 10.1002/pmic.200500345
7
Yang Tang, Yidi Cui, Shufeng Zhang, Lijuan Zhang. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part AProgress in Molecular Biology and Translational Science 2019; 162: 121 doi: 10.1016/bs.pmbts.2019.01.010
8
Antonio Moral, José Magarzo. Marcadores tumorales serológicos en cirugía hepatobiliopancreáticaCirugía Española 2004; 76(5): 276 doi: 10.1016/S0009-739X(04)72378-7
9
B.C. Visser, V.R. Muthusamy, B.M. Yeh, F.V. Coakley, L.W. Way. Diagnostic evaluation of cystic pancreatic lesionsHPB 2008; 10(1): 63 doi: 10.1080/13651820701883155
10
George Vasiliades, Nikolaos Kopanakis, Michalis Vasiloglou, George Zografos, Helias Margaris, Kyriaki Masselou, Evniki Kokosi, Theodore Liakakos. Role of the hematopoietic cytokines SCF, IL-3, GM-CSF and M-CSF in the diagnosis of pancreatic and ampullary cancerThe International Journal of Biological Markers 2012; 27(3): 186 doi: 10.5301/JBM.2012.9348
11
Chao-Xu Zheng, Wen-Hua Zhan, Ji-Zong Zhao, Dong Zheng, Dong-Ping Wang, Yu-Long He, Zhang-Qing Zheng. Prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancerWorld Journal of Gastroenterology 2001; 7(3): 431-434 doi: 10.3748/wjg.v7.i3.431
12
Jun-Ming Guo, Bing-Xiu Xiao, De-Jian Dai, Qiong Liu, Hong-Hui Ma. Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells <i>in vitro</i>World Journal of Gastroenterology 2004; 10(6): 860-863 doi: 10.3748/wjg.v10.i6.860
13
Lane C. Patten, David H. Berger. Role of Proteases in Pancreatic CarcinomaWorld Journal of Surgery 2005; 29(3): 258 doi: 10.1007/s00268-004-7816-3
14
Min Zheng, Lian-Xin Liu, An-Long Zhu, Shu-Yi Qi, Hong-Chi Jiang, Zhu-Ying Xiao. <i>K-ras</i> gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic massesWorld Journal of Gastroenterology 2003; 9(1): 188-191 doi: 10.3748/wjg.v9.i1.188
15
Xiaozhong Guo, Zhongmin Cui. Current Diagnosis and Treatment of Pancreatic Cancer in ChinaPancreas 2005; 31(1): 13 doi: 10.1097/01.mpa.0000168220.97967.d1
16
MASAHIRO TANAKA, NOBUKAZU KOMATSU, YASUAKI YANAGIMOTO, MASAO OKA, SHIGEKI SHICHIJO, SEIYA OKUDA, KYOGO ITOH. Development of a New Diagnostic Tool for Pancreatic Cancer: Simultaneous Measurement of Antibodies against Peptides Recognized by Cytotoxic T LymphocytesThe Kurume Medical Journal 2006; 53(3/4): 63 doi: 10.2739/kurumemedj.53.63
17
Chunlin Ge, Ning Ma, Dianbo Yao, Fengming Luan, Chaojun Hu, Yongzhe Li, Yongfeng Liu. A serum Biomarker model to diagnose pancreatic cancer using proteomic fingerprint technologyChinese Journal of Clinical Oncology 2008; 5(3): 200 doi: 10.1007/s11805-008-0200-6
18
Felix Rückert, Christian Pilarsky, Robert Grützmann. Serum Tumor Markers in Pancreatic Cancer—Recent DiscoveriesCancers 2010; 2(2): 1107 doi: 10.3390/cancers2021107
19
E. Coban, M. Samur, H. Bozcuk, M. Ozdogan. The Value of CEA and CA 19-9 in Detecting Cancer in a Group of High-Risk Subjects with Gastrointestinal SymptomsThe International Journal of Biological Markers 2003; 18(3): 177 doi: 10.1177/172460080301800304
20
Min-Pei Liu, Xiao-Zhong Guo, Jian-Hua Xu, Di Wang, Hong-Yu Li, Zhong-Min Cui, Jia-Jun Zhao, Li-Nan Ren. New tumor-associated antigen SC6 in pancreatic cancerWorld Journal of Gastroenterology 2005; 11(48): 7671-7675 doi: 10.3748/wjg.v11.i48.7671
21
Ying-Nai Wang, Heng-Huan Lee, Mien-Chie Hung. A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinasesJournal of Biomedical Science 2018; 25(1) doi: 10.1186/s12929-018-0484-7
22
Dan Du, Feng Yan, Shengli Liu, Huangxian Ju. Immunological assay for carbohydrate antigen 19-9 using an electrochemical immunosensor and antigen immobilization in titania sol–gel matrixJournal of Immunological Methods 2003; 283(1-2): 67 doi: 10.1016/j.jim.2003.08.014
23
Ning Ma, Chun-lin Ge, Feng-ming Luan, Dian-bo Yao, Chao-jun Hu, Ning Li, Yong-feng Liu. Serum protein fingerprint of patients with pancreatic cancer by SELDI technologyChinese Journal of Cancer Research 2008; 20(3): 171 doi: 10.1007/S11670-008-0171-4